• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 vaccine impact in Israel and a way out of the pandemic.

作者信息

Leshem Eyal, Wilder-Smith Annelies

机构信息

The Chaim Sheba Medical Centre, RamatGan 52621, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; Heidelberg Global Health Institute, University of Heidelberg, Heidelberg, Germany.

出版信息

Lancet. 2021 May 15;397(10287):1783-1785. doi: 10.1016/S0140-6736(21)01018-7. Epub 2021 May 5.

DOI:10.1016/S0140-6736(21)01018-7
PMID:33964221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8099312/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ed/8099312/7c0bc65dd532/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ed/8099312/7c0bc65dd532/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ed/8099312/7c0bc65dd532/fx1_lrg.jpg

相似文献

1
COVID-19 vaccine impact in Israel and a way out of the pandemic.新冠疫苗在以色列的影响以及走出疫情大流行的途径。
Lancet. 2021 May 15;397(10287):1783-1785. doi: 10.1016/S0140-6736(21)01018-7. Epub 2021 May 5.
2
Signals of hope: gauging the impact of a rapid national vaccination campaign.希望的信号：评估全国快速疫苗接种运动的影响。
Nat Rev Immunol. 2021 Apr;21(4):198-199. doi: 10.1038/s41577-021-00531-0.
3
Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 - a review.信使核糖核酸疫苗用于严重急性呼吸综合征冠状病毒 2-综述。
Transl Res. 2022 Apr;242:1-19. doi: 10.1016/j.trsl.2021.12.007. Epub 2021 Dec 23.
4
Blunting COVID-19's negative impact: Lessons from Israel's vaccination campaign.减轻新冠疫情的负面影响：以色列疫苗接种运动的经验教训
Travel Med Infect Dis. 2021 May-Jun;41:102029. doi: 10.1016/j.tmaid.2021.102029. Epub 2021 Mar 16.
5
Audio Interview: Waning Immunity against SARS-CoV-2.音频访谈：针对严重急性呼吸综合征冠状病毒2的免疫力下降
N Engl J Med. 2021 Dec 9;385(24):e99. doi: 10.1056/NEJMe2119211.
6
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.在以色列全国范围内使用辉瑞-生物科技公司的 BNT162b2 mRNA COVID-19 疫苗进行疫苗接种运动，以预防感染、住院和死亡：一项回顾性监测研究。
Lancet Infect Dis. 2022 Mar;22(3):357-366. doi: 10.1016/S1473-3099(21)00566-1. Epub 2021 Sep 22.
7
[THE NEED FOR REDUCING DISPARITIES IN SARS-COV-2 IMMUNIZATION: THE ULTRAORTHODOX AND ARAB POPULATIONS IN ISRAEL].[减少新冠病毒免疫接种差距的必要性：以色列的极端正统派和阿拉伯人群]
Harefuah. 2021 May;160(5):285-290.
8
Medical imaging in times of pandemic: focus on the cornerstones of successful imaging.疫情时期的医学影像：聚焦成功成像的基石。
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1724-1725. doi: 10.1007/s00259-021-05331-1.
9
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.BNT162b2疫苗接种者中SARS-CoV-2感染和新冠肺炎的早期感染率降低情况。
Lancet. 2021 Mar 6;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Epub 2021 Feb 18.
10
Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel.BNT162b2 疫苗加强针对 SARS-CoV-2 感染和突破感染并发症的有效性，以色列。
Emerg Infect Dis. 2022 May;28(5):948-956. doi: 10.3201/eid2805.220141. Epub 2022 Apr 1.

引用本文的文献

1
Factors Explaining Responses to Influenza and COVID-19 Vaccination Among Nurses in Israel.以色列护士对流感疫苗和新冠疫苗接种反应的影响因素
Vaccines (Basel). 2025 Apr 24;13(5):454. doi: 10.3390/vaccines13050454.
2
Developing and validating a culturally tailored questionnaire to assess COVID-19 vaccine hesitancy in Israel's ultraorthodox Jewish population.开发并验证一份针对文化定制的问卷，以评估以色列极端正统犹太人群体中对新冠疫苗的犹豫态度。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2429233. doi: 10.1080/21645515.2024.2429233. Epub 2024 Dec 5.
3
Vaccine inequity: a threat to Africa's recovery from COVID-19.

本文引用的文献

1
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals.有证据表明，在接种 BNT162b2 mRNA 疫苗的人群中，SARS-CoV-2 变异株的突破性感染率有所增加。
Nat Med. 2021 Aug;27(8):1379-1384. doi: 10.1038/s41591-021-01413-7. Epub 2021 Jun 14.
2
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.以色列全国疫苗接种运动后，mRNA BNT162b2疫苗对SARS-CoV-2感染及COVID-19病例、住院和死亡的影响与效果：一项利用国家监测数据的观察性研究
Lancet. 2021 May 15;397(10287):1819-1829. doi: 10.1016/S0140-6736(21)00947-8. Epub 2021 May 5.
3
疫苗不平等：对非洲从新冠疫情中复苏的威胁。
Trop Med Health. 2023 Dec 19;51(1):69. doi: 10.1186/s41182-023-00564-2.
4
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments.接受积极抗肿瘤治疗的癌症患者接种第三剂和第四剂BNT162b2疫苗的反应率
Diseases. 2023 Sep 26;11(4):128. doi: 10.3390/diseases11040128.
5
Association between COVID-19 vaccination and critical outcomes among older adults with dementia: a comparative cohort study.COVID-19 疫苗接种与老年痴呆症患者重症结局的关联：一项对照队列研究。
Front Public Health. 2023 Oct 2;11:1281266. doi: 10.3389/fpubh.2023.1281266. eCollection 2023.
6
The critical factors for COVID-19 vaccination uptake are perceived ‎vaccine effectiveness and the desire to protect others.影响民众对 COVID-19 疫苗接种意愿的关键因素是对疫苗有效性的认知和保护他人的愿望。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2265170. doi: 10.1080/21645515.2023.2265170. Epub 2023 Oct 17.
7
Policy Disparities Between Singapore and Israel in Response to the First Omicron Wave.新加坡和以色列应对首例奥密克戎毒株浪潮时的政策差异
Risk Manag Healthc Policy. 2023 Apr 2;16:489-502. doi: 10.2147/RMHP.S402813. eCollection 2023.
8
Risk Stratification Model for Severe COVID-19 Disease: A Retrospective Cohort Study.重症新型冠状病毒肺炎疾病风险分层模型：一项回顾性队列研究。
Biomedicines. 2023 Mar 2;11(3):767. doi: 10.3390/biomedicines11030767.
9
A Game-Theory-Based Approach to Promoting Health Policy among Minorities.基于博弈论的少数民族健康政策促进方法。
Int J Environ Res Public Health. 2023 Feb 28;20(5):4335. doi: 10.3390/ijerph20054335.
10
Graft rejection in component keratoplasty.异体成分角膜移植中的排斥反应。
Indian J Ophthalmol. 2023 Mar;71(3):698-706. doi: 10.4103/ijo.IJO_1964_22.
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.英格兰医护人员的 COVID-19 疫苗接种率和 BNT162b2 mRNA 疫苗对感染的有效性（SIREN）：一项前瞻性、多中心、队列研究。
Lancet. 2021 May 8;397(10286):1725-1735. doi: 10.1016/S0140-6736(21)00790-X. Epub 2021 Apr 23.
4
Population immunity and vaccine protection against infection.群体免疫与疫苗对感染的防护作用。
Lancet. 2021 May 8;397(10286):1685-1687. doi: 10.1016/S0140-6736(21)00870-9. Epub 2021 Apr 23.
5
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.苏格兰首次大规模 COVID-19 疫苗接种和 COVID-19 住院的临时发现：一项全国性前瞻性队列研究。
Lancet. 2021 May 1;397(10285):1646-1657. doi: 10.1016/S0140-6736(21)00677-2. Epub 2021 Apr 23.
6
Access to COVID-19 vaccines: looking beyond COVAX.获得新冠疫苗：超越新冠疫苗全球获取机制（COVAX）的视角
Lancet. 2021 Mar 13;397(10278):941. doi: 10.1016/S0140-6736(21)00617-6.
7
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.确保全球公平获得 COVID-19 疫苗面临的挑战：生产、可负担性、分配和部署。
Lancet. 2021 Mar 13;397(10278):1023-1034. doi: 10.1016/S0140-6736(21)00306-8. Epub 2021 Feb 12.
8
Israel's rapid rollout of vaccinations for COVID-19.以色列为 COVID-19 推出的疫苗快速接种计划。
Isr J Health Policy Res. 2021 Jan 26;10(1):6. doi: 10.1186/s13584-021-00440-6.
9
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
10
Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak.隔离、检疫、社交距离和社区管控：旧型公共卫生措施在新型冠状病毒（2019-nCoV）疫情中的关键作用。
J Travel Med. 2020 Mar 13;27(2). doi: 10.1093/jtm/taaa020.